Article Information
History
- October 23, 2020.
Article Versions
- Version 1 (October 13, 2020 - 09:12).
- You are currently viewing Version 2 of this article (October 23, 2020 - 10:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
REVISION SUMMARY
This version was revised to fit the correct asymptomatic to symptomatic ratio reported in the serology study in Spain (from 0.5/0.5 to 0.34/0.66). Needed A_o60 changes from 0.28 to 0.21 and A_u60 from 0.71 to 0.52. It has minimal impact on results (e.g. Madrid immunity level estimation from 43% to 41%).
Posted October 23, 2020.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
6
Blogs/Media
Author Videos